Literature DB >> 7509265

Aprotinin therapy to reduce blood loss in Jehovah's Witnesses.

H Litvan, E Santacana, J I Casas, A Aris, J M Villar Landeira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7509265     DOI： 10.1007/bf03009674

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN： 0832-610X            Impact factor:   5.063


× No keyword cloud information.
  5 in total

1.  Preoperative erythropoietin in Jehovah's Witnesses who require cardiac procedures.

Authors:  V A Gaudiani; H D Mason
Journal:  Ann Thorac Surg       Date:  1991-05       Impact factor: 4.330

2.  Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency.

Authors:  B P Bidstrup; S R Underwood; R N Sapsford; E M Streets
Journal:  J Thorac Cardiovasc Surg       Date:  1993-01       Impact factor: 5.209

3.  Hypervolaemic haemodilution in an anaemic Jehovah's Witness.

Authors:  A Trouwborst; R R Hagenouw; J Jeekel; G L Ong
Journal:  Br J Anaesth       Date:  1990-05       Impact factor: 9.166

4.  Unplanned intraoperative and postoperative hemodilution: oxygen transport and consumption during severe anemia.

Authors:  A Lichtenstein; W F Eckhart; K J Swanson; C A Vacanti; W M Zapol
Journal:  Anesthesiology       Date:  1988-07       Impact factor: 7.892

5.  DDAVP to reduce blood loss in Jehovah's Witnesses.

Authors:  D J Stone; C A DiFazio
Journal:  Anesthesiology       Date:  1988-12       Impact factor: 7.892
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.